ARGX Q2 2019 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$45B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$51M+150.3% YoY

Gross Profit

-$27M-52.6% margin

Operating Income

-$54M-106.2% margin

Net Income

-$45M-88.0% margin

EPS (Diluted)

$-1.19

Cash Flow

Operating Cash Flow

$228M

Free Cash Flow

$228M

Stock-Based Comp.

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$20M	+150.3%
Gross Profit	-$27M	-$14M	-94.7%
Operating Income	-$54M	-$25M	-114.5%
Net Income	-$45M	-$20M	-124.8%

Geographic Segments

L

$27M63%

C

$15M36%

D

$128,0000%